Abstract:Background and objectives: Discoveries of dermatomyositis-specific antibodies (DMSAs) in patients with dermatomyositis raised awareness of various myopathologic features among antibody subtypes. However, only perifascicular atrophy and perifascicular myxovirus resistant protein A (MxA) overexpression were officially included as definitive pathologic criteria for dermatomyositis classification. We aimed to demonstrate myopathologic features in MxA-positive dermatomyositis to determine characteristic myopathologic features in different DMSA subtypes. Methods: We performed a retrospective pathology review of muscle biopsies of patients with dermatomyositis diagnosed between January 2009 and December 2020 in a tertiary laboratory for muscle diseases. We included all muscle biopsies with sarcoplasmic expression for MxA and seropositivity for DMSAs. MxA-positive muscle biopsies that tested negative for all DMSAs were included as seronegative dermatomyositis. We evaluated histologic features stratified according to 4 pathology domains (muscle fiber, inflammatory, vascular, and connective tissue) and histologic features of interest by histochemistry, enzyme histochemistry, and immunohistochemical study commonly used in the diagnosis of inflammatory myopathy. We performed ultrastructural studies of 54 available specimens. Results: A total of 256 patients were included. Of these, 249 patients were positive for 1 of the 5 DMSAs (seropositive patients: 87 anti-transcription intermediary factor 1-γ [TIF1-γ], 40 anti-complex nucleosome remodeling histone deacetylase [Mi-2], 29 anti-melanoma differentiation gene 5 [MDA5], 83 anti-nuclear matrix protein 2 [NXP-2], and 10 anti-small ubiquitin-like modifier-activating enzyme [SAE] dermatomyositis) and 7 patients were negative for all 5 DMSAs (seronegative patients). Characteristic myopathologic features in each DMSA subtype were as follows: anti-TIF1-γ with vacuolated/punched out fibers (64.7%; p < 0.001) and perifascicular enhancement in HLA-ABC stain (75.9%; p < 0.001); anti-Mi-2 with prominent muscle fiber damage (score 4.9 ± 2.1; p < 0.001), inflammatory cell infiltration (score 8.0 ± 3.0; p = 0.002), perifascicular atrophy (67.5%; p = 0.02), perifascicular necrosis (52.5%; p < 0.001), increased perimysial alkaline phosphatase activity (70.0%; p < 0.001), central necrotic peripheral regenerating fibers (45.0%; p = 0.002), and sarcolemmal membrane attack complex deposition (67.5%; p < 0.001); anti-MDA5 with scattered/diffuse staining pattern of MxA (65.5%; p < 0.001) with less muscle pathology and inflammatory features; anti-NXP-2 with microinfarction (26.5%; p < 0.001); and anti-SAE and seronegative dermatomyositis with HLA-DR expression (50.0%; p = 0.02 and 57.1%; p = 0.02, respectively). Discussion: We describe a comprehensive serologic-pathologic correlation of dermatomyositis primarily using MxA expression as an inclusion criterion. In our study, DMSAs were associated with distinctive myopathologic features suggesting different underlying pathobiologic mechanisms in each subtype.

Clinical And Muscular Pathological Characteristics Of Hypomyopathic Dermatomyositis: An Analysis Of Six Cases

The cfinical and pathological features of hypomyopathic dermatomyositis: a report of 6 cases

Polymyositis and Dermatomyositis Biomarkers

Assessment of Thigh MRI Radiomics and Clinical Characteristics for Assisting in Discrimination of Juvenile Dermatomyositis.

Dermatomyositis: Muscle Pathology According to Antibody Subtypes

Pathological Characteristics of Juvenile Dermatomyositis ,six Cases Reported

Deep Pathological Phenotyping of Dermatomyositis with Different Autoantibodies

Analysis of Muscular Pathological Features in Different Types of Connective Tissue Diseases

Immunopathological Changes of Micro-Vessels in Dermatomyositis

Evolution of Seronegative Inflammatory Myositis to Dermatomyositis With Characteristic Cutaneous Features: A Case Report

Comparison of Clinical and Immunological Features Between Clinically Amyopathic Dermatomyositis and Typical Dermatomyositis

A retrospective study for clinical characteristics of 293 patients with dermatomyositis

Pathological Characteristics of Myotonic Dystrophy

Common Variable Immunodeficiency with Muscle Hypertrophy and Myotonia Myositis

Dermatomyositis: Clinical features and pathogenesis

Myositis Specific Autoantibodies: A Clinical Perspective

Mitochondrial morphology and MAVS-IFN1 signaling pathway in muscles of anti-MDA5 dermatomyositis

Cutaneous signs of classical dermatomyositis

Clinical and muscular pathological features with chronic graft-versus-host disease-related polymyositis: one case report

A rare form of dermatomyositis associated with muscle weakness and normal creatine kinase level

Reduction Expression of Thrombomodulin and Endothelial Cell Nitric Oxide Synthase in Dermatomyositis